San Diego-based Illumina has teamed up with German-based Merck Serono and Australia-based Genea to form a consortium known as Global Fertility Alliance for Excellence in Assisted Reproductive Treatment.

The consortium will gather at the 31st annual meeting of the European Society of Human Reproduction and Embryology on June 13 in Lisbon, Portugal.

"Illumina has a strong commitment to improving in vitro fertilization outcomes through the use of industry leading genomics but appreciates that there are many factors that impact ART outcomes,” said Tristan Orpin, Illumina's senior vice president and general manager of reproductive and genetic health in a statement.

Illumina (Nasdaq: ILMN) is a developer, manufacturer and marketer of life science tools and systems of genetic analysis.